Aravax Company
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Employee Number:
11-50
Investors Number:
2
Funding Status:
Seed
Headquarters:
Melbourne, Victoria, Australia
Technology:
Cancer
Founded Date:
2015
Last Funding Type:
Seed
Investor Type:
For Profit
Industry:
PharmTech